Introduction

GMP facility audits play an important role in maintaining quality, safety, and compliance in pharmaceutical manufacturing. These audits help organizations identify weaknesses in facility conditions, cleaning practices, equipment maintenance, environmental monitoring, and documentation. Addressing these issues early can reduce compliance risks and improve overall operational performance.

Many pharmaceutical facilities face similar audit findings because of incomplete records, outdated procedures, missed maintenance activities, or inconsistent implementation of established processes. If these issues are not addressed promptly, they may lead to repeated observations and affect inspection readiness.

Understanding GMP facility audits common findings helps organizations prepare more effectively and maintain stronger quality systems. In this guide, we discuss six common facility audit findings, practical ways to prevent them, and how GxP Cellators supports pharmaceutical companies through professional GMP auditing services.

What Are GMP Facility Audits?

GMP facility audits are systematic reviews of facility conditions, supporting systems, procedures, and records to assess whether applicable Good Manufacturing Practices (GMP) requirements are being followed. The scope may include cleaning, maintenance, pest control, environmental monitoring, equipment calibration, and documentation.

Depending on the facility and audit objectives, an audit may cover manufacturing areas, storage spaces, laboratories, utilities, and other controlled environments. Auditors review documented procedures, observe actual practices, examine records, and identify gaps that may affect product quality or compliance.

Regular facility audits help organizations identify risks before they become larger problems. They also support corrective and preventive actions, continuous improvement, and preparation for regulatory inspections.

Six Common Findings in GMP Facility Audits and How to Prevent Them

1. Inadequate Cleaning and Sanitation

Cleaning is essential for maintaining hygienic conditions in pharmaceutical facilities. Inadequate cleaning procedures, incomplete cleaning records, or inconsistent execution can create risks related to contamination and product quality.

During a facility audit, auditors may find that cleaning activities are not documented correctly, cleaning frequencies are not followed, or personnel cannot demonstrate that established procedures have been completed.

How to Prevent Cleaning-Related Findings

• Review cleaning procedures regularly to ensure they reflect current facility requirements.
• Train personnel on approved cleaning methods, responsibilities, and acceptance criteria.
• Maintain complete and accurate cleaning records for relevant areas and equipment.
• Establish appropriate cleaning frequencies based on documented risk assessments.
• Conduct periodic cleaning audits to verify that procedures are followed in practice.
• Investigate recurring cleaning issues and implement suitable corrective actions.

Cleaning records should reflect the activities actually performed. Supervisors should also review records for missing entries, unexplained discrepancies, and incomplete approvals.

2. Poor Facility and Equipment Maintenance

Poor maintenance is another common issue identified during GMP facility audits. Overdue preventive maintenance, incomplete work orders, and unresolved facility defects may affect equipment reliability and the controlled conditions required for pharmaceutical operations.

For example, damaged surfaces, malfunctioning doors, or poorly maintained equipment may create operational or contamination risks. The significance of each issue depends on its location, impact, and intended use.

How to Prevent Maintenance-Related Findings

• Maintain an approved preventive maintenance schedule for facilities, equipment, and relevant utilities.
• Document completed maintenance activities, including work performed and required approvals.
• Review maintenance records regularly to identify overdue tasks and recurring failures.
• Assess the impact of maintenance delays on product quality and facility operations.
• Address defects according to their risk and potential effect on GMP activities.
• Verify that equipment or areas are suitable for use before returning them to operation, where required.

A structured maintenance program helps organizations move from reactive repairs to planned activities. It also provides documented evidence that facility systems remain suitable for their intended use.

3. Pest Control Issues

Pest control is important for maintaining suitable conditions in pharmaceutical manufacturing, storage, and other relevant areas. Inadequate pest control programs, missing inspection records, or delayed responses to pest activity may become audit findings.

Auditors may review pest control procedures, monitoring devices, inspection reports, service records, and the investigation of any identified pest activity.

How to Prevent Pest Control Findings

• Implement a documented pest control program appropriate to the facility and its risks.
• Maintain current records of inspections, monitoring activities, and pest control treatments.
• Inspect relevant areas regularly for signs of pest activity or conditions that may attract pests.
• Investigate pest sightings and document the actions taken.
• Review pest control service reports and follow up on outstanding recommendations.
• Ensure that pest control activities do not introduce contamination risks into manufacturing or storage areas.

Pest control records should be reviewed for recurring trends. Repeated activity in the same area may indicate an underlying problem that requires further investigation rather than repeated short-term treatment.

4. Inadequate Environmental Monitoring

Environmental monitoring helps organizations evaluate whether facility conditions remain suitable for the activities performed in a particular area. Depending on the facility, this may involve monitoring temperature, humidity, pressure differentials, particulate levels, or microbiological conditions.

Audit findings may arise when monitoring programs are incomplete, records are missing, monitoring frequencies are not followed, or results outside established limits are not investigated appropriately.

How to Prevent Environmental Monitoring Findings

• Establish an environmental monitoring program based on facility design, intended use, and documented risks.
• Define appropriate monitoring locations, frequencies, methods, and acceptance criteria.
• Maintain complete environmental monitoring records and review the results regularly.
• Investigate results outside established limits and document the assessment and follow-up actions.
• Evaluate trends to identify recurring issues or changes in environmental conditions.
• Verify that monitoring instruments are suitable for their intended use and maintained as required.

Environmental monitoring should not be treated as a recordkeeping exercise alone. Reviewing trends and investigating unusual results helps organizations identify potential weaknesses before they affect operations or product quality.

5. Equipment Calibration Issues

Equipment calibration supports the reliability of measurements used in pharmaceutical manufacturing, testing, and facility monitoring. Instruments that are overdue for calibration or have incomplete calibration records can create uncertainty about the validity of recorded results.

During GMP facility audits, auditors may examine calibration schedules, certificates, instrument identification, status labels, and procedures for handling equipment that fails calibration requirements.

How to Prevent Calibration-Related Findings

• Maintain an up-to-date calibration schedule for instruments requiring calibration.
• Document calibration activities, results, and approvals according to approved procedures.
• Review calibration records to identify overdue activities and missing documentation.
• Clearly identify equipment status where required by site procedures.
• Investigate calibration failures and assess the impact on previous measurements or affected operations.
• Prevent the use of equipment that is unsuitable for its intended purpose.

Calibration failures should be assessed based on their potential impact. Where necessary, organizations should investigate affected measurements, document decisions, and implement corrective actions to reduce the risk of recurrence.

6. Documentation Gaps and Outdated Records

Documentation gaps are common findings across GMP facility audits. These may include incomplete cleaning logs, missing maintenance records, outdated procedures, inconsistent entries, or insufficient evidence that required activities were reviewed and approved.

Accurate documentation helps demonstrate that activities were performed according to approved procedures. Missing or unreliable records can make it difficult to establish whether a process was properly controlled.

How to Prevent Documentation Findings

• Review documentation procedures to ensure that responsibilities and requirements are clearly defined.
• Train personnel on accurate recordkeeping and applicable good documentation practices.
• Establish review and approval processes for relevant records.
• Periodically review procedures to identify outdated instructions and obsolete versions.
• Investigate missing records, discrepancies, and documentation errors according to approved procedures.
• Conduct internal documentation audits to identify recurring weaknesses.

Documentation should be completed at the appropriate time by authorized personnel. Records must remain accurate, traceable, and consistent with applicable procedures and data integrity requirements.

How to Manage GMP Facility Audit Findings Effectively

Identifying an audit finding is only the first step. Organizations must also evaluate its significance, determine the underlying cause, and establish appropriate actions.

A structured approach helps ensure that findings are addressed consistently and that corrective actions lead to sustainable improvements.

1. Record and Classify Each Finding

Document each finding clearly, including the observed condition, relevant evidence, applicable procedure, and potential impact. Classify findings according to the organization’s approved risk assessment process.

2. Investigate the Root Cause

Determine why the issue occurred rather than addressing only the immediate symptom. Depending on the finding, the investigation may examine training, procedures, maintenance planning, supervision, equipment, or workload.

3. Establish Corrective and Preventive Actions

Corrective and preventive action (CAPA) plans should define the actions required, responsible personnel, target dates, and expected outcomes. Actions should be proportionate to the risk and supported by documented reasoning.

4. Verify That Actions Are Effective

Completing an action does not automatically demonstrate that the issue has been resolved permanently. Organizations should verify effectiveness using appropriate evidence, such as record reviews, follow-up audits, or monitoring of recurring issues.

5. Maintain Complete Audit Records

Keep audit reports, supporting evidence, investigations, action plans, and follow-up records organized and accessible to authorized personnel. Good record management helps demonstrate progress and supports future audits and inspections.

How GxP Cellators Supports GMP Facility Audits

GxP Cellators provides GMP auditing services to help pharmaceutical and other regulated organizations identify facility-related compliance gaps and develop practical corrective actions.

The audit scope can be tailored to the facility, its operations, applicable requirements, and identified risks. This approach helps organizations focus on areas that require attention instead of relying on a one-size-fits-all audit checklist.

Our Facility Audit Services Include

• Full-scope facility audits.
• Cleaning and sanitation audits.
• Facility and equipment maintenance audits.
• Pest control audits.
• Environmental monitoring audits.
• Equipment calibration audits.
• Documentation and recordkeeping audits.
• Mock inspections to support inspection readiness.
• CAPA verification and follow-up.

Why Choose GxP Cellators?

GxP Cellators focuses on practical findings and actionable recommendations that organizations can use to strengthen their quality systems.

Key benefits include:

• Relevant industry experience: Auditors with regulatory inspection and industry quality experience.
• Regulatory awareness: Consideration of applicable FDA, EMA, Health Canada, MHRA, and WHO requirements, depending on the audit scope.
• Risk-based approach: Audit activities tailored to facility operations and identified compliance risks.
• Actionable reporting: Findings and recommendations presented to support investigation and remediation.
• Confidentiality: Appropriate protection of proprietary information and facility records.

Professional auditing support can help organizations identify weaknesses, prioritize remediation, and improve the consistency of their compliance processes.

To discuss your requirements, visit the GxP Cellators Contact Page.

Conclusion

GMP facility audits help pharmaceutical organizations identify weaknesses in cleaning, maintenance, pest control, environmental monitoring, equipment calibration, and documentation. These findings can often be reduced through clear procedures, trained personnel, accurate records, regular reviews, and effective CAPA management.

A proactive audit program also helps organizations identify recurring issues and improve inspection readiness. Rather than waiting for an external inspection to reveal problems, facilities can use internal audits and independent auditing support to evaluate their practices and address gaps in a planned manner.

GxP Cellators provides GMP auditing services designed to help regulated organizations assess facility compliance and identify practical improvement opportunities. Contact the team to discuss your facility audit needs and develop an approach suited to your operations.

Contact GxP Cellators: https://www.gxpcellators.com/contact/

Frequently Asked Questions

1. What are common findings in GMP facility audits?

Common findings include inadequate cleaning, overdue maintenance, pest control weaknesses, incomplete environmental monitoring, overdue equipment calibration, and documentation gaps. The significance of each finding depends on its potential impact on product quality, facility operations, and applicable GMP requirements.

2. How can cleaning findings be prevented during a GMP facility audit?

Cleaning findings can be reduced by maintaining approved cleaning procedures, training personnel, following established cleaning frequencies, documenting activities accurately, and conducting periodic reviews. Organizations should also investigate recurring problems and verify that corrective actions are effective.

3. How can maintenance-related GMP audit findings be prevented?

Organizations should maintain preventive maintenance schedules, document completed work, review overdue activities, and address facility defects according to risk. Equipment and areas should be assessed before returning to use when required by approved procedures.

4. Why is environmental monitoring important in GMP facility audits?

Environmental monitoring provides evidence about whether relevant facility conditions remain within established limits. Reviewing monitoring records and trends helps organizations identify unusual results, investigate potential risks, and demonstrate that appropriate controls are maintained.

5. How does GxP Cellators help address facility audit findings?

GxP Cellators provides GMP facility auditing support to identify compliance gaps, review relevant procedures and records, and recommend practical corrective actions. The audit scope can be tailored to the organization’s operations and identified risks.

6. How can a company prepare for a GMP facility audit?

A company can prepare by reviewing procedures and records, checking maintenance and calibration schedules, verifying cleaning and pest control activities, reviewing environmental monitoring data, and ensuring that previous audit findings have been addressed. Personnel should understand their responsibilities and follow approved procedures.

7. How do I contact GxP Cellators for GMP facility audit support?

You can contact GxP Cellators through its official contact page to discuss your facility audit requirements and the support appropriate for your organization.